Heat shock treatment with mild electrical stimulation safely reduced inflammatory markers in healthy male subjects

Summary Objective Obesity induces chronic inflammation, which contributes to the development and progression of insulin resistance, diabetes and atherosclerosis. We have recently shown that induction of heat shock protein 72 by mild electric current and thermo (MET) treatment in mouse model of type...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity research & clinical practice 2010-04, Vol.4 (2), p.e101-e109
Hauptverfasser: Kondo, Tatsuya, Sasaki, Kazunari, Adachi, Hironori, Nakayama, Yoshiharu, Hatemura, Masahiro, Matsuyama, Rina, Tsuruzoe, Kaku, Furukawa, Noboru, Motoshima, Hiroyuki, Morino (Koga), Saori, Yamashita, Yasuyuki, Miyamura, Nobuhiro, Kai, Hirofumi, Araki, Eiichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Objective Obesity induces chronic inflammation, which contributes to the development and progression of insulin resistance, diabetes and atherosclerosis. We have recently shown that induction of heat shock protein 72 by mild electric current and thermo (MET) treatment in mouse model of type 2 diabetes ameliorated glucose homeostasis and insulin resistance accompanied by reduced adiposity. For clinical application of MET, we confirmed its safety in healthy subjects. Methods MET was applied for 10 healthy Japanese male (12 V, 55 pulses/s, 30 min at 42 °C) twice a week for 8 weeks. Fat volume was measured by CT scan and several parameters were investigated. Results MET did not induce any adverse effects nor muscle contraction/pain. There were no significant alterations in glucose homeostasis or insulin resistance. Visceral and subcutaneous fat volume showed a trend of decrease without significant difference (−3.9% and −4.3%, respectively), which were restored 8 weeks after withdrawal of MET. Interestingly, serum tumor necrosis factor-α (TNF-α: 0.91 ± 0.05 pg/mL vs. 0.67 ± 0.06 pg/mL; p = 0.006) and high sensitivity C-reactive protein (hs-CRP: 521.9 ± 73.9 ng/mL vs. 270.8 ± 43.7 ng/mL; p = 0.023) levels, both of which are associated with chronic inflammation, were significantly decreased. Conclusion MET may be beneficial for the reduction of an inflammatory response observed in diabetes and metabolic syndrome.
ISSN:1871-403X
DOI:10.1016/j.orcp.2009.09.007